Afuco™ Anti-ITGA5 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-077)

CAT#: AFC-TAB-077

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to Integrin Integrin alpha 5 beta 1. It is a chimeric monoclonal antibody jointly for treatment of a variety of advanced solid tumors. It binds to and inhibits the functional activity of α5β1 integrin.
It is thought to reduce metastases. Early results show potential in renal cell cancers.

Gene Expression
Figure 1 High expression in placenta Figure 2 Low expression in skeletal muscle Figure 3 IHC staining of human placenta Figure 4 Liver Figure 5 Placenta Figure 6 RNA cell line category: Cell line enhanced (hTERT-RPE1, HUVEC TERT2, TIME, U-87 MG)

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Chimeric
  • Derivation
  • Chimeric (mouse/human)
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • IP, IF, FuncS, FC, Neut, ELISA
  • Conjugate
  • Unconjugated
  • Generic Name
  • Volociximab
  • Related Disease
  • Unknown

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • ITGA5; integrin, alpha 5 (fibronectin receptor, alpha polypeptide); FNRA; integrin alpha-5; CD49e; VLA-5; integrin alpha-F; CD49 antigen-like family member E; fibronectin receptor subunit alpha; fibronectin receptor, alpha subunit;
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-077. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "Volociximab"

Anti-Human Integrin alpha 5 beta 1 Recombinant Antibody (Volociximab)
Recombinant monoclonal antibody to Integrin Integrin alpha 5 beta 1. Volociximab (also known as M200) is a chimeric monoclonal antibody jointly for treatment of a variety of advanced solid tumors. It binds to and inhibits the functional activity of α5β1 integrin.
It is thought to reduce metastases. Early results show potential in renal cell cancers.
DrugMonitor™ Anti-Volociximab Antibody (VS-1224-YC1312)
Volociximab is a chimeric monoclonal antibody developed for treating various advanced solid tumors. The DrugMonitor™ Anti-Volociximab Antibody (VS-1224-YC1312) is an anti-drug antibody (ADA) against Volociximab. This drug-based antibody is raised in mice immunized with the Volociximab. The anti-Volociximab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Volociximab in samples.

See other products for "ITGA5"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
TAB-077 Anti-Human Integrin alpha 5 beta 1 Recombinant Antibody (Volociximab) ELISA, IHC IgG4
CAT Product Name Application Type
MOR-1874 Hi-Affi™ Recombinant Rabbit Anti-ITGA5 Monoclonal Antibody (DS1874AB) WB, IHC-P, ICC, IF, IP, FC IgG
CAT Product Name Application Type
VS-0724-YC1485 AbPlus™ Anti-ITGA5 Magnetic Beads (VS-0724-YC1485) IP, Protein Purification
CAT Product Name Application Type
VS-0425-FY136 Rabbit Anti-ITGA5 scFv-Fc Chimera (VS-0425-FY136) ELISA, Flow, ICC, IF, IHC, BLOCK Rabbit IgG, scFv-Fc
CAT Product Name Application Type
VS-0425-YC570 Recombinant Anti-ITGA5 Vesicular Antibody, EV Displayed (VS-0425-YC570) ELISA, FC, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare